Proctor, L.L.; Ward, W.L.; Roggy, C.S.; Koontz, A.G.; Clark, K.M.; Quinn, A.P.; Schroeder, M.; Brooks, A.E.; Small, J.M.; Towne, F.D.;
et al. Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections. Antibiotics 2021, 10, 1530.
https://doi.org/10.3390/antibiotics10121530
AMA Style
Proctor LL, Ward WL, Roggy CS, Koontz AG, Clark KM, Quinn AP, Schroeder M, Brooks AE, Small JM, Towne FD,
et al. Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections. Antibiotics. 2021; 10(12):1530.
https://doi.org/10.3390/antibiotics10121530
Chicago/Turabian Style
Proctor, Luke L., Whitney L. Ward, Conner S. Roggy, Alexandra G. Koontz, Katie M. Clark, Alyssa P. Quinn, Meredith Schroeder, Amanda E. Brooks, James M. Small, Francina D. Towne,
and et al. 2021. "Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections" Antibiotics 10, no. 12: 1530.
https://doi.org/10.3390/antibiotics10121530
APA Style
Proctor, L. L., Ward, W. L., Roggy, C. S., Koontz, A. G., Clark, K. M., Quinn, A. P., Schroeder, M., Brooks, A. E., Small, J. M., Towne, F. D., & Brooks, B. D.
(2021). Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections. Antibiotics, 10(12), 1530.
https://doi.org/10.3390/antibiotics10121530
